The Effect of Uterine Manipulator Use During Abdominal Hysterectomy on Postoperative Sexual Function
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorErkan Gol
About this trial
This prospective, single-center, randomized controlled trial aims to evaluate the effect of uterine manipulator use during total abdominal hysterectomy on postoperative female sexual function at 3 months, assessed by the Female Sexual Function Index (FSFI). Secondary outcomes include operative time, perioperative hemoglobin change, postoperative pain (VAS), hospital stay duration, and 30-day complications.
Eligibility criteria
Qualifiers
Women aged ≥18 years
Planned total abdominal hysterectomy for benign indications
Sexually active within the last 4 weeks
Able to complete the Female Sexual Function Index (FSFI) questionnaire
Disqualifiers
Gynecologic malignancy
Major additional pelvic reconstructive surgery
Severe psychiatric or neurologic disorder
Inability to complete follow-up assessments
Trial design
Treatments tested in this trial
- Uterine Manipulator
- Conventional Abdominal Hysterectomy
Treatment groups
60 Participants
are divided into 2 treatment groupsLocations
1Bakirkoy Dr. Sadi Konuk Training and Research Hospital34147, IstanbulIstanbul, Turkey (Türkiye)
Sponsors and collaborators
Erkan Gol
Lead sponsor
Bakirkoy Dr. Sadi Konuk Research and Training Hospital
Sponsor institution
Source ClinicalTrials.gov